Lily Dara
University of Southern California
Appearances
DateMay 18, 2024METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITISModerators
Indiana UniversityUniversity of Southern CaliforniaSpeakers
University of Nevada Las Vegas School of Medicine
